Podcast

Understanding Precision Medicine in Multiple Myeloma

Author(s):

Kristie L. Kahl

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Cesar Rodriguez about precision medicine, and his recent trek to Patagonia with Moving Mountains for Multiple Myeloma.

Dr. Cesar Rodriguez has spent the last seven years dedicated to advancing the field of multiple myeloma — which he discussed in this week’s episode of the “CURE Talks Cancer” podcast.

Rodriguez highlighted advances with precision medicine in the multiple myeloma treatment landscapes, and common questions patients have for their physicians.

Moreover, he also highlighted his recent trek to Patagonia with Moving Mountains for Multiple Myeloma, an effort partnered by CURE and the Multiple Myeloma Research Foundation. Through the trek, Rodriguez was able to meet with patients and their caregivers about a disease he has spent his career dedicated to finding more treatments for.

For more information, visit movingmountainsformultiplemyeloma.com.

Related Videos
Dr. Mikhael in an interview with CURE
Dr. Ajai Chari in an in interview with CURE
An image of Dr. Patel in an interview with CURE discussing healthy lifestyles in myeloma
Dr. Munshi in an interview with CURE
Dr. Dikran Kazandjian during an interview with CURE
Related Content
Image of multiple myeloma cells.
December 21st 2024

Darzalex Regimen May Improve MRD Responses in Multiple Myeloma

Kristie L. Kahl
Patients newly diagnosed with multiple myeloma who are transplant ineligible or deferred may benefit from receiving a Darzalex treatment combination.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of Dr. Brandon Blue.
December 17th 2024

Black Patients With Myeloma Face Taste, Skin Side Effects from Talvey

Alex Biese
Black patients may be more affected by certain side effects from Talvey compared with White patients with multiple myeloma, an expert told CURE®.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Illustration of cancer cells representing multiple myeloma.
December 9th 2024

Tecvayli Effective Maintenance Therapy in Newly Diagnosed Multiple Myeloma

Jason Broderick
Tecvayli alone or plus Revlimid has been found to be safe and may result in high MRD-negativity rates.
Illustration of multiple myeloma in the bone marrow.
December 9th 2024

Darzalex Faspro May Improve Progression, Survival in Smoldering Multiple Myeloma

Kristie L. Kahl
The risk for disease progression or death was reduced by 51% with subcutaneous Darzalex Faspro in certain patients with smoldering multiple myeloma.